NDRA Initiates Strategic Review, Engages Lucid as Advisor, K&L Gates Counsel, Evaluates M&A, Partnerships, Asset Sales, No Timeline, Focus on Shareholder Value
ENDRA Life Sciences Inc. Common Stock · ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS · Now $5.60
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS